Overview

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The aim of study is to evaluate the results of three different protocols for prevention of premature ovulation in ovarian stimulation cycles. All patients that undergo IVF cycles are randomly divided into three groups. The first group is cetrorelix, the second group is medroxyprogesterone acetate and the third group is dydrogesterone.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Bezmialem Vakif University
Treatments:
Cetrorelix
Dydrogesterone
Hormone Antagonists
Hormones
Medroxyprogesterone
Medroxyprogesterone Acetate
Criteria
Inclusion Criteria:

- Women aged 20-38 years who applied to the infertility clinic

- BMI<25 kg/m2

- AMH>1 ng/mL

Exclusion Criteria:

- Adenomyosis

- Endometriosis

- Untreated uterine pathology

- Hormonal therapy in the last 3 months

- Contraindication for ovulation stimulation

- BMI>25 kg/m2

- AMH<1 ng/mL